Published in Cochrane Database Syst Rev on January 01, 2004
Multiplicative disadvantage of being an unmarried and inadequately insured woman living in poverty with colon cancer: historical cohort exploration in California. BMC Womens Health (2015) 0.99
How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews. BMC Palliat Care (2008) 0.95
Lack of access to chemotherapy for colon cancer: multiplicative disadvantage of being extremely poor, inadequately insured and African American. BMC Health Serv Res (2014) 0.94
Unmet supportive care needs in colorectal cancer: differences by age. Support Care Cancer (2011) 0.91
Surveillance of patients following surgery with curative intent for colorectal cancer. World J Gastroenterol (2007) 0.85
Best supportive care in clinical trials: review of the inconsistency in control arm design. Br J Cancer (2015) 0.80
Systematic review of escalated imatinib doses compared with sunitinib or best supportive care, for the treatment of people with unresectable/metastatic gastrointestinal stromal tumours whose disease has progressed on the standard imatinib dose. J Gastrointest Cancer (2012) 0.79
Review: chemotherapy plus supportive care improves survival and quality of life in advanced or metastatic gastrointestinal cancer more than supportive care alone. Evid Based Nurs (2005) 0.79
Challenges of advanced hepatocellular carcinoma. World J Gastroenterol (2016) 0.77
Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting. Support Care Cancer (2012) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer (1994) 3.45
What investigations and procedures do patients in hospices want? Interview based survey of patients and their nurses. BMJ (1997) 3.41
Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene (2006) 2.20
What do hospices do? A survey of hospices in the United Kingdom and Republic of Ireland. BMJ (1990) 1.70
A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res (1988) 1.70
Dying in hospital: the residents' viewpoint. Br Med J (Clin Res Ed) (1982) 1.45
Palliative care in oncology: making quality the endpoint. Ann Oncol (1990) 1.43
Xerostomia--a review. Palliat Med (1996) 1.36
Human immunodeficiency virus infection associated arthritis: clinical characteristics. J Rheumatol (1999) 1.07
Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice. Int J Clin Pract (2011) 1.04
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study. Eur J Cancer Clin Oncol (1984) 1.02
A regional survey of opioid use by patients receiving specialist palliative care. Palliat Med (1995) 0.97
High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung. Cancer Chemother Pharmacol (1985) 0.92
Costs of palliative care in the community, in hospitals and in hospices in the UK. Crit Rev Oncol Hematol (1999) 0.89
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Br J Cancer (1983) 0.85
Willingness to pay and conjoint analysis to determine women's preferences for ovarian stimulating hormones in the treatment of infertility in Spain. Hum Reprod (2011) 0.84
Muscular strength and bone mineral density in haemodialysis patients. Nephrol Dial Transplant (1997) 0.83
A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. Br J Cancer (2004) 0.81
Resuscitation and patients' views. Terminally ill patients may want to live. BMJ (1994) 0.81
Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir. J Viral Hepat (2013) 0.81
Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect (2011) 0.81
Prevalence and characteristics of rheumatic manifestations in patients infected with human immunodeficiency virus undergoing antiretroviral therapy. J Rheumatol (1997) 0.80
Arterial pressure as a determinant of left ventricular filling pressure after acute myocardial infarction. Am J Cardiol (1974) 0.79
Intracranial metastases from malignant pleural mesothelioma. Scand J Thorac Cardiovasc Surg (1995) 0.76
Short duration combination chemotherapy in the treatment of small cell lung cancer. Thorax (1986) 0.76
Skeletal and hormonal responses to vitamin D supplementation during sunlight deprivation in Antarctic expeditioners. Osteoporos Int (2012) 0.75
Treatment for cancer pain. BMJ (1995) 0.75
The other information revolution. Ann Oncol (1997) 0.75
Palliative care of patients with terminal cancer. Curr Opin Oncol (1993) 0.75
[Prevalence of chronic bronchitis in an urban and a rural area of Santiago and its relation to the degree of air pollution]. Rev Med Chil (1972) 0.75
Piperidinium 3-[(4-hydroxy-5-dimethyl-2-oxo-2H-chromen-3-yl)-phenylmethyl]-5,7-dimethyl-2-oxo-2H-chromen-4-olate. Acta Crystallogr C (2001) 0.75
[Tuberculous peritonitis in HIV-infected patients]. Rev Argent Microbiol (2010) 0.75
Experience with dipipanone elixir in the management of cancer related pain--case study. Palliat Med (1994) 0.75
Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesna. Cancer Treat Rev (1983) 0.75
Bone mineral density in a native population of Argentina with low calcium intake. J Rheumatol (1995) 0.75
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer Group. Semin Oncol (1985) 0.75
Project will assess effects of patients writing about their terminal illness on self perceived quality of life. BMJ (1997) 0.75